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BACKGROUND

INTERVENTION

• Colorectal cancer (CRC) screening has been proven to be a
feasible, cost-effective way to reduce incidence of and
mortality from CRC.

• Our primary intervention was to offer GI referral for colonoscopy,
and for patients who refused screening colonoscopy, FIT was
offered as an alternative.

• CRC is the second-leading cause of cancer-related death in
the United States.

• A secondary intervention was educating residents about the
importance of colon cancer screening, how to discuss colon cancer
screening options with their patients, and how to teach their
patients to properly use FIT kits.

• As early CRC is asymptomatic, it is imperative that we detect
it early to reduce mortality.
• Despite the widespread availability of CRC screening, CRC
screening rates in our ambulatory sites have been below
average.
• The Wednesday Jefferson Hospital Ambulatory Practice
(JHAP) resident clinic’s CRC screening rate was 44.3% in
September 2016 as compared to an average of 57% at other
ambulatory sites in the Greater Philadelphia region.
Therefore, CRC screening was targeted as an area of quality
improvement.
• Our goals were to implement an intervention to improve
CRC screening rates in our practice as well as identify sitespecific obstacles to CRC screening that could be intervened
on in the future.
• Fecal Immunochemical Test (FIT) is a FDA approved CRC
screening modality for one year.

AIM STATEMENT
Our aim at Wednesday JHAP was to increase the rate of
colorectal cancer screenings from 44.3% to 60% from
September 2o16 to May 2017 (9 months)

RESULTS

• In November 2016, resident physicians started calling patients who
were due for CRC screening to arrange CRC screening. Reasons for
patient noncompliance or nonadherence were documented.
• Then, since February 2017, patients who still required CRC
screening were again contacted via phone and/or mail to set up CRC
screening.

DISCUSSION
• Despite not reaching our AIM, we were able to increase our
colon cancer screening rate by 16% from 9/2016 to 5/2017
• The most common barrier to colon cancer screening
reported was difficulty scheduling a colonoscopy. Future
steps include collaborating with GI to develop a more
efficient and effective colonoscopy scheduling system and
having multiple resident education sessions to train
residents on how to effectively educate patients about FIT as
an alternative CRC screening option.
• The second most common barrier identified by patients was
fear of colonoscopy. We hoped that offering FIT testing
would be a suitable alternative for these patients. A future
direction is a handout for patients addressing common
patient concerns regarding colonoscopy and providing
further information to allow for greater patient education
and reassurance.
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